<DOC>
	<DOCNO>NCT00954668</DOCNO>
	<brief_summary>Of estimate 140,000 case acute myocardial infarction admit hospital Germany per year , approximately 50 % present Non-ST-elevation myocardial infarction ( NSTEMI ) . The currently available evidence lead current guideline recommendation systematic approach immediate angiography NSTEMI patient stabilize contemporary antiplatelet treatment mandatory . However , immediate invasive approach appeal allows treat underlying cause ( plaque rupture ) early possible subsequent reduction death recurrent myocardial infarction . In IDEAL NSTEMI trial test immediate invasive approach ( &lt; 2 h ) approach 12-72 h accord top guideline respect 6 month death mortality .</brief_summary>
	<brief_title>ImmeDiate Versus EArLy Invasive Approach Non-ST-Elevation Myocardial Infarction ( IDEAL NSTEMI )</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>NSTEMI ischemic symptom &gt; 10 minute within 24 h elevate troponin creatine kinase upper limit normal STsegment depression transient STsegment elevation , Twave inversion inform consent . Age &lt; 18 year Age &gt; 90 year persistent angina hemodynamic instability overt congestive heart failure lifethreatening arrhythmias STEMI limit lifeexpectancy &lt; 6 month chronic oral anticoagulation fibrinolysis &lt; 48 hour PCI &lt; 14 day contraindication treatment glycoprotein IIb/IIIa inhibitor , heparin , aspirin clopidogrel recent major trauma surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Non-ST-elevation myocardial infarction</keyword>
	<keyword>angiography</keyword>
	<keyword>percutaneous coronary intervention</keyword>
	<keyword>timing</keyword>
</DOC>